Peptidic sulfhydryl for interfacing nanocrystals and subsequent sensing of SARS-CoV-2 protease

Z Jin, J Yeung, J Zhou, Y Cheng, Y Li… - Chemistry of …, 2022 - ACS Publications
Chemistry of Materials, 2022ACS Publications
There is a need for surveillance of COVID-19 to identify individuals infected with SARS-CoV-
2 coronavirus. Although specific, nucleic acid testing has limitations in terms of point-of-care
testing. One potential alternative is the nonstructural protease (nsp5, also known as
Mpro/3CLpro) implicated in SARS-CoV-2 viral replication but not incorporated into virions.
Here, we report a divalent substrate with a novel design,(Cys) 2–(AA) x–(Asp) 3, to interface
gold colloids in the specific presence of Mpro leading to a rapid and colorimetric readout …
There is a need for surveillance of COVID-19 to identify individuals infected with SARS-CoV-2 coronavirus. Although specific, nucleic acid testing has limitations in terms of point-of-care testing. One potential alternative is the nonstructural protease (nsp5, also known as Mpro/3CLpro) implicated in SARS-CoV-2 viral replication but not incorporated into virions. Here, we report a divalent substrate with a novel design, (Cys)2–(AA)x–(Asp)3, to interface gold colloids in the specific presence of Mpro leading to a rapid and colorimetric readout. Citrate- and tris(2-carboxyethyl)phosphine (TCEP)-AuNPs were identified as the best reporter out of the 17 ligated nanoparticles. Furthermore, we empirically determined the effects of varying cysteine valence and biological media on the sensor specificity and sensitivity. The divalent peptide was specific to Mpro, that is, there was no response when tested with other proteins or enzymes. Furthermore, the Mpro detection limits in Tris buffer and exhaled breath matrices are 12.2 and 18.9 nM, respectively, which are comparable to other reported methods (i.e., at low nanomolar concentrations) yet with a rapid and visual readout. These results from our work would provide informative rationales to design a practical and noninvasive alternative for COVID-19 diagnostic testing─the presence of viral proteases in biofluids is validated.
ACS Publications
以上显示的是最相近的搜索结果。 查看全部搜索结果